SEC Form 4 · accession 0001645470-19-000003
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan Brian Collier
Officer — CEO
Period of report
Jan 14, 2019
Accepted (ET)
Jan 15, 2019 · 5:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 14, 2019 | P | 5,000 | $0.034 | A | 20,606,123 | D | |
| Common Stock | Jan 14, 2019 | P | 5,000 | $0.034 | A | 20,611,123 | D | |
| Common Stock | Jan 14, 2019 | P | 10,000 | $0.0329 | A | 20,621,123 | D | |
| Common Stock | Jan 14, 2019 | P | 5,000 | $0.0327 | A | 20,626,123 | D | |
| Common Stock | Jan 14, 2019 | P | 5,000 | $0.0329 | A | 20,631,123 | D | |
| Common Stock | Jan 14, 2019 | P | 5,000 | $0.0327 | A | 20,636,123 | D | |
| Common Stock | Jan 14, 2019 | P | 5,000 | $0.0327 | A | 20,641,123 | D | |
| Common Stock | Jan 14, 2019 | P | 5,000 | $0.0326 | A | 20,646,123 | D |
Table II — derivative securities
No Table II lines on this filing.